The DCT OS Report: More than 95% of biopharma executives say we're not going back to a site-based-only development model. Learn more

The Clinical Trial of the Future

How the accelerated adoption of agile clinical trials will reshape the research landscape in 2022.

S37_ACT_GatedPage_Graphic.png
Science 37®, the Operating System™ that powers agile clinical trials, has released important study findings and new data on the evolution of clinical trials.

Learn more about:

  • Why agile clinical trials are important for patients, physicians, and sponsors

  • What the clinical trial of the future will look like and why it’s less likely to be fully traditional or fully decentralized

  • Which therapeutic areas and study phases will see the biggest increases in decentralized activity

  • How empowering diversity in clinical trials is a key step toward closing the health equity gap

  • And, key steps CROs and sponsors should take to empower the clinical trial of the future

Access the report, the webinar recording and a slide presentation by filling in the form opposite.